Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Clinical trial NCT02242487 · COMPLETED

Trial details

NCT number: NCT02242487
Sponsor: Acorda Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Parkinson's Disease

Start date: 2015-03-01
Primary completion: 2018-05-01
Enrollment: 325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.